White & Case Advised Zentiva On Its Sale By Advent To GTCR

White & Case advised Zentiva on its sale by Advent to GTCR

White & Case LLP advised Zentiva Group a.s (Zentiva), a leading European generics pharmaceutical company, on its sale by Advent International to GTCR LLC (GTCR), as well as certain shareholders on their reinvestment.

Prague-based Zentiva focuses on the development, production, and delivery of high-quality, affordable medicines, serving over 100 million people in more than 30 countries.

Advent, which acquired Zentiva in 2018, transformed the business into a successful standalone company through organic growth and targeted M&A, strengthening operational excellence and expanding R&D capabilities. Chicago-based GTCR, known for its deep domain expertise in healthcare, particularly pharmaceuticals, continues to focus its investment strategy in the sector.

The White & Case team advising on the transaction was led by Helen Croke (Partner, London), with support from Vaclav Kubr (Partner, Prague), Jessica Kemp (Partner, London), Michael Evans (Partner, London), Annika Randhawa (Partner, London), Sara Nordin (Partner, Brussels), Dominik Stier (Local Partner, Frankfurt), and associates Trishala Naidu, Kikelomo Lawal, Ashwini Mohan, Amy Detheridge, Aliya Manji, Alice Parsons, and Emma Middleton (all London).

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.